Skip to main content
Clinical Trials/CTRI/2021/05/033863
CTRI/2021/05/033863
Not yet recruiting
未知

A Pre-clinical and Clinical Study to evaluate the efficacy ofAshwagandhadi Avaleha as an Adjuvant in the management ofTuberculosis with Anti Tubercular Treatment.

Principal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J989- Respiratory disorder, unspecified
Sponsor
Principal
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Principal

Eligibility Criteria

Inclusion Criteria

  • 1\. Freshly diagnosed cases of tuberculosis(Pulmonary Tuberculosis and Tubercular pleural
  • 2\. Patients of either sex between the age of 15\-70 years.
  • 3\. Patients willing and able to participate for 8 weeks duration

Exclusion Criteria

  • 1\. MDR and XDR cases of tuberculosis.
  • 2\. Patients having diabetes mellitus.
  • 3\. Patient with uncontrolled hypertension.
  • 4\. Suffering from any other chronic infections including HIV.
  • 5\. Patients Below the age of 15yrs and above the age of 70yrs.
  • 6\. Patients not willing for trial.
  • 7\. Individuals who have completed participation in any other clinical trial during the past three
  • 8\. Any other condition which the Principal investigator thinks may jeopardize the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials